Staar Surgical reported $81.1M in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbott ABT:US $ 11257M 638M
Atrion ATRI:US 48.88M 8.59M
Boston Scientific BSX:US $ 3244M 218M
Cerus CERS:US $ 47.63M 4.61M
Cooper Companies COO:US $ 843.4M 13.6M
Exact Sciences EXAS:US $ 521.64M 35.07M
Hologic HOLX:US $ 1002.7M 433M
Johnson & Johnson JNJ:US $ 24020M 594M
Meridian Bioscience VIVO:US $ 67.77M 43.46M
Merit Medical Systems MMSI:US $ 294.98M 19.56M
Novartis NOVN:VX SF 13085M 271M
Orasure Technologies OSUR:US $ 160.46M 92.76M
Orthofix International OFIX:US $ 118.07M 11.65M
Rockwell Medical RMTI:US $ 18.68M 2.56M
Sientra SIEN:US $ 21.51M 0.12M
Staar Surgical STAA:US $ 81.1M 17.9M
Utah Medical Products UTMD:US $ 13.43M 856K
Valeant Pharmaceuticals VRX:CN $ 2531.92M 613.92M